help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henson, M. C.
Right arrow Articles by Shi, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henson, M. C.
Right arrow Articles by Shi, W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 7 2543-2549
Copyright © 1999 by The Endocrine Society


From the Clinical Research Centers

Serum Leptin Concentrations and Expression of Leptin Transcripts in Placental Trophoblast with Advancing Baboon Pregnancy1

Michael C. Henson, V. Daniel Castracane, Jennifer S. O’Neil, Terry Gimpel, Kenneth F. Swan, Amy E. Green and Wenliang Shi

Departments of Obstetrics/Gynecology (M.C.H., J.S.O., K.F.S., W.S.), Physiology (M.C.H., W.S.), and Anatomy (M.C.H.) and the Interdisciplinary Program in Molecular and Cellular Biology (M.C.H., J.S.O., A.E.G.), Tulane University School of Medicine, New Orleans, Louisiana 70112-2699; Tulane Regional Primate Research Center (M.C.H.), Covington, Louisiana 70433-8915; and the Department of Obstetrics/Gynecology, Texas Tech University Health Sciences Center (V.D.C., T.G.), Amarillo, Texas 79106-1797

Address all correspondence and requests for reprints to: Michael C. Henson, Ph.D., Department of Obstetrics/Gynecology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, Louisiana 70112-2699. E-mail: michael.henson{at}tulane.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Leptin is a polypeptide hormone originally thought to be produced exclusively by adipocytes. Recently, however, both leptin messenger ribonucleic acid (mRNA) and leptin protein were identified in human placental trophoblast cells, suggesting a potential role in primate pregnancy. In the present study, venous blood samples were collected at 5-day intervals during gestation from baboons (Papio sp), an established model for the study of human pregnancy, as well as from nonpregnant baboons, and leptin concentrations were determined by RIA. Additionally, placental villous tissue was collected upon cesarean delivery at early (days 60–62; n = 5), mid (days 98–102; n = 5), and late (days 159–167; n = 5) gestation (term = ~184 days), and leptin mRNA was quantitated by competitive RT-PCR. Finally, in situ hybridization was employed to localize transcripts to specific placental cell types. Results determined that maternal leptin levels (mean ± SEM), which were dramatically greater (P < 0.01) than those in nonpregnant cycling baboons (1.4 ± 0.1 ng/mL), increased (P < 0.005) with gestational age from 63.6 ± 10.4 ng/mL on day 60 of gestation to 157.8 ± 16.1 near term. Levels declined to those found in cycling baboons by 15 days postdelivery. In contrast to maternal leptin concentrations, placental leptin mRNA decreased (P < 0.02) with advancing pregnancy, as transcript abundance declined approximately 8-fold from early to late gestation. Maternal peripheral leptin concentrations were positively correlated (r = 0.66; P < 0.001) whereas placental leptin mRNA levels were negatively correlated (r = -0.64; P < 0.01) with gestational age. Expression of leptin mRNA transcripts, as evidenced by RT-PCR in villous tissue, was localized principally within syncytiotrophoblast by in situ hybridization.

In summary, changes in maternal peripheral leptin concentrations and placental leptin mRNA abundance that occur commensurate with advancing gestational age may imply evolving roles for the polypeptide with advancing primate pregnancy. In this capacity, localization of leptin transcripts within the baboon syncytiotrophoblast suggests the potential for autocrine or paracrine interactions within this endocrinologically active tissue. Finally, both the similarities in leptin ontogeny in baboon and human pregnancy and the singular enhancement of maternal leptin levels inherent throughout baboon gestation emphasize the potential of this nonhuman primate model for the study of leptin action in the maternal-fetoplacental unit.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
LEPTIN, a hormone commonly produced and secreted by adipose cells, is a product of the obese (ob) gene. It has been implicated as a factor that is at least partially responsible for the regulation of body weight in several species, including humans (1). Administration of the 167-amino acid polypeptide induces satiety and results in weight loss in genetically obese rodent species through action via a specific hypothalamic receptor. Although the mechanism by which leptin regulates body composition in humans is not yet completely understood, plasma levels are correlated with body mass index, and a decrease in body fat is associated with a decline in the peripheral leptin concentration (2). Indeed, leptin-associated mechanisms regulating body weight and growth in humans may be more complex than first suspected, as interplay with various hormonal axes may impact leptin’s ability to modulate adipose mass with respect to energy expenditure (3).

Leptin is also linked to a variety of reproductive processes. Therefore, although female mice that are genotypically homozygous for the ob gene are obese, leptin deficient, and sterile, treatment with exogenous leptin readily restores fertility. However, simple restoration of normal body weight via food restriction alone had no appreciable effect (4). In similar experiments, leptin-treated ob/ob females exhibited elevated LH levels, increased ovarian and uterine weights, and stimulated ovarian and uterine histology compared to untreated controls. Leptin-treated ob/ob males evidenced enhanced FSH levels, increased testicular and seminal vesicle weights, and elevated sperm counts (5). Leptin-treated, genetically normal, prepuberal females reached reproductive maturity at a dramatically earlier age than did untreated controls and evidenced accelerated maturation of the reproductive tract (6). Therefore, it has been hypothesized that the polypeptide may serve as either a primary signal initiating puberty or a permissive regulator of sexual maturation (7). Also linking leptin with reproduction, leptin receptor messenger ribonucleic acid (mRNA) transcripts are expressed in the ovary, uterus, testis, hypothalamus, and anterior pituitary, as well as in granulosa cells in the rat (8), whereas in women undergoing in vitro fertilization, leptin mRNA and leptin protein have been determined in both granulosa and cumulus cells (9).

Intriguingly, women exhibit significantly higher peripheral serum leptin levels than men, even when matched in regard to adipose mass (10). During pregnancy, maternal concentrations rise with advancing gestation (11) and until parturition are significantly higher than postpartum (12). In addition to leptin produced in adipose tissue, a significant amount of the polypeptide measured in the maternal periphery may originate in the placenta, and the expression of both leptin (13, 14, 15) and leptin receptor (16, 17) transcripts has been detected in villous tissue. Immunohistochemical staining of term human placenta has localized leptin (14) and leptin receptor protein (17) to trophoblast cells. Recently, we reported the presence of mRNA transcripts for leptin and two leptin receptor isoforms within human syncytiotrophoblast by in situ hybridization and, using, competitive RT-PCR, determined a diminution in leptin transcript abundance commensurate with advancing gestation (18).

Although a number of possible roles for leptin in perinatal development and the endocrinology of pregnancy have been proposed, little has been definitively determined with regard to leptin ontogeny with advancing human pregnancy. Thus, further characterization of a well validated nonhuman primate model (19) from which blood and tissue samples may be collected throughout gestation may be efficacious. The objectives of the current study, therefore, were to 1) quantitate serum leptin concentrations in both pregnant as well as normally cycling and postpartum nonpregnant baboons, 2) determine the presence of mRNA transcripts for leptin in placental villous tissue throughout gestation, 3) evaluate changes in leptin levels and placental transcription relative to gestational age, and 4) localize mRNA transcripts for leptin within specific cell types of the placenta.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals

Animals were maintained and used strictly in accordance with USDA regulations and the Guide for the Care and Use of Laboratory Animals (NIH Publication 86–23). The experimental protocol was approved by the institutional care and use committee of the Tulane Regional Primate Research Center (Covington, LA). Thus, 15 female baboons (Papio sp), weighing 14–17 kg, were individually housed in stainless steel cages as previously described (19, 20, 21). A 12-h light photoperiod (0600–1800 h) was maintained in air-conditioned rooms, and animals received a primate maintenance ration with fresh fruit daily and water ad libitum. Females were quartered with males for mating in indoor/outdoor enclosures for 4–5 days, coinciding with the estimated occurrence of ovulation, as determined by daily menstrual cycle records and visible turgescence of external sex skin. Blood samples were obtained from nonpregnant baboons and from pregnant baboons at regular intervals from days 60–160 of gestation (term = ~184 days). Therefore, at 0800–0900 h a 6-mL blood sample was withdrawn from an antecubital vein via a 21-gauge needle after brief restraint and sedation with an im injection of ketamine HCl (10–15 mg/kg BW; Ketalar, Fort Dodge Pharmaceuticals, Fort Dodge, IA). The extended sample collection period during gestation (100 days) was deemed necessary to establish a reliable baseline profile for maternal peripheral leptin.

Baboon placental tissue was obtained upon cesarean delivery, as previously described, under isofluorane anesthesia after sedation with ketamine HCl/atropine (21), early in gestation (days 60–62; n = 5), at midgestation (days 98–102; n = 5), or late in gestation (days 159–167; n = 5). Thus, immediately after laparotomy, a hysterotomy was performed, and the fetus and placenta were delivered. As we have previously described (22), samples of placental villous tissue were collected from the maternal surface, from areas equidistant between the cord attachment and the outer rim of the placental disc. Tissue was then flash-frozen in liquid nitrogen for storage at -80 C. Tissue samples were also fixed (Histochoice, Amresco, Solon, OH) for in situ hybridization.

Leptin RIA

Serum samples were stored at -20 C until leptin concentrations were determined by RIA (Linco Research, Inc., St. Charles, MO), as we have previously described (23), employing an antibody against human leptin. Inter- and intraassay coefficients of variation (n = 5) for leptin were 8.7% and less than 5.0%, respectively, with a sensitivity of 0.5 ng/mL. The human assay was validated for the baboon using a pregnant serum pool, where serial dilutions yielded concentrations that were linear and parallel to those in human serum.

RNA extraction and RT-PCR

Total RNA was isolated from placental villous tissue using TRIzol reagent (Life Technologies, Grand Island, NY) according to the method of Chomczynski and Sacchi (24) and Chirgwin et al. (25) as adapted for use in our laboratory (18). Oligonucleotide primers were synthesized (Midland Reagent Co., Midland, TX) according to the sequences for leptin (18) and the constitutively expressed housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (21). PCR primer sequences and product sizes are as follows: leptin (235-bp product): 5'-primer, 5'-GACTTCATTCCTGGGCTCCACC-3'; 3'-primer, 5'-CCTGAAGCTTCCAGGACACC-3'; and GAPDH (240-bp product): 5'-primer, 5'-TGATGACATCAAGAAGGTGGTGAAG-3'; 3'-primer, 5'-TCCTTGGAGGCCATGTAGGCCAT-3'. Sequences for oligonucleotide primers for leptin exhibit approximately 50% GC content and were designed to be RNA specific by spanning the junction of two exons. Oligonucleotides anneal to specific gene sequences (as referenced by GenBank accession numbers) at the following nucleotide positions: leptin (U18915): 5'-primer, 181–202; 3'-primer, 397–416; and GAPDH (M33197): 5'-primer, 825–849; 3'-primer, 1042–1064. Sequence analysis of PCR products (Biotech Core, Palo Alto, CA) confirmed the specificity of this primer pair to leptin mRNA. Complimentary DNAs (cDNAs) were synthesized from 2 µg total RNA using the SuperScript kit (Life Technologies), and PCR was performed in a Temp-Tronic Thermocycler (Barnstead/Thermolyne, Dubuque, IA) as previously reported in our laboratory (18, 21). Conditions for PCR were: leptin, 40 cycles for amplification, denaturation at 95 C for 30 s, hybridization at 55 C for 30 s, extension at 72 C for 60 s; and GAPDH, 24 cycles for amplification, denaturation at 94 C for 30 s, hybridization at 58 C for 60 s, extension at 72 C for 60 s. PCR products were visualized in 2% agarose gels containing ethidium bromide. PCR reactions were accompanied by controls, including 1) GAPDH as a positive cDNA synthesis control, 2) RNA that had not been transcribed into cDNA as a genomic DNA contamination control, and 3) sterile water blanks as a reagent control. After semiquantitative assessment of mRNA transcripts by comparison of leptin PCR products with GAPDH (21, 24), quantitative competitive RT-PCR was performed using the PCR MIMIC Construction Kit (CLONTECH Laboratories, Inc., Palo Alto, CA), as we have previously described (18). Thus, products were resolved by 2% agarose gel electrophoresis, and band intensities were analyzed using the Alpha Imager 2000 digital analysis system (Alpha Inotech, San Leandro, CA). Final concentrations were expressed as attomoles per µg RNA (1 attomole = ~6 x 105 molecules).

In situ hybridization

Paraffin-embedded tissue sections (6 µm) were floated onto the surface of SuperFrost Plus microscope slides (Labcraft, Fisher Scientific, Norwalk, GA) and fixed overnight at 37 C. Just before analysis, slides were baked (1 h, 65 C), deparaffinized, and in situ hybridization for leptin was performed using a 5'-biotinylated oligonucleotide (Midland Reagent Co.), as we have previously reported (18). Thus, the antisense (3') oligonucleotide primer used for PCR was used as the hybridization probe, and the sense strand (5') primer was used as a negative control for the specificity of hybridization. Hybridization was detected using the In Situ Hybridization and Detection Kit (Life Technologies). Sections were mounted for photomicroscopy with Histomount (Zymed, San Francisco, CA).

Statistical analysis

Standard least squares ANOVAs using the general linear models procedure, followed by mean separation according to the Student- Newman-Keuls method of the Statistical Analysis System (26), was employed to assess the effects of gestational stage on measured parameters. Pearson product-moment correlation coefficients were also generated. Significant differences were understood to exist when P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Peripheral serum leptin levels were determined in both pregnant and nonpregnant baboons by RIA. As illustrated in Fig. 1Go, the mean ± SEM peripheral serum leptin concentration in pregnant baboons (n = 5) between days 60–160 of gestation was 125.2 ± 11.4 ng/mL compared to 1.4 ± 0.1 ng/mL in nonpregnant animals in the luteal phase of the menstrual cycle (n = 6) and 1.8 ± 0.1 ng/mL in nonpregnant animals 15–18 days after cesarean delivery (n = 4). Therefore, although leptin concentrations in nonpregnant (cycling vs. postpartum) animals were similar (P > 0.05), concentrations of the peptide in pregnant animals were dramatically higher (P < 0.01) than those in either cycling or postpartum baboons. Further, to obtain a reliable gestational profile for leptin, maternal blood samples were collected at intervals throughout pregnancy, and serum levels were determined (Fig. 2Go). Thus, maternal leptin concentrations increased approximately 2.5-fold (P < 0.005) between day 60 (63.6 ± 10.4 ng/mL) and day 160 (157.8 ± 16.1 ng/mL) of gestation. In addition, subsequent to cesarean delivery in both early and late gestation, maternal blood samples were collected for 15–18 days postpartum, and serum leptin were quantitated. After both early pregnancy delivery (days 58 and 64; n = 2) and near term delivery (days 162 and 165; n = 2), maternal leptin levels plummeted (P < 0.005) within 15 days, to levels comparable to those found in nonpregnant females (Fig. 3Go).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Peripheral serum leptin concentrations (mean ± SEM) in cycling (n = 6), pregnant (n = 5), and postcesarean delivery (CDEL; n = 6) baboons. Different lowercase letters indicate significant differences between means (a and b, P < 0.01).

 


View larger version (14K):
[in this window]
[in a new window]
 
Figure 2. Maternal peripheral serum leptin concentrations in baboons sampled from days 60–160 of gestation (normal term, ~184 days). Each data point represents the mean (±SEM) of four to six animals.

 


View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Maternal peripheral serum leptin concentrations in baboons after cesarean delivery in early gestation (A), days 58 ({blacksquare}) and 64 (•) of pregnancy, and in late gestation (B), days 162 ({square}) and 165 ({circ}) of pregnancy. CDEL, Cesarean delivery.

 
Specific mRNA transcripts for leptin were determined in placental villous tissue collected at early (days 60–62; n = 5), mid (days 98–102; n = 5), and late (days 159–167; n = 5) pregnancy. Because an equivalent amount of RNA was used in all RT-PCR reactions, an initial qualitative assessment was made with respect to constitutively expressed GAPDH. This comparison is presented in Fig. 4Go, A and B. Although expression of GAPDH mRNA transcripts was similar at all stages of pregnancy, the abundance of leptin transcripts appeared to decline with respect to increasing gestational age. This potential decrease in leptin mRNA prompted competitive quantitative assessment of leptin transcripts by the PCR MIMIC method. With respect to this quantitative analysis, leptin mRNA transcript abundance declined from 0.068 ± 0.021 attomoles/µg RNA early in gestation to 0.035 ± 0.011 at midgestation to 0.009 ± 0.003 near term (Fig. 5AGo). Thus, leptin transcripts in placental villous tissue decreased approximately 8-fold between early and late gestation (P < 0.02). Commensurately, maternal serum leptin levels increased slightly less than 3-fold between early (63.6 ± 10.4 ng/mL), mid (98.0 ± 10.0), and late (157.8 ± 16.1) gestation (Fig. 5BGo), and in late pregnancy, therefore, these levels were significantly greater (P < 0.005) than at either early or midgestation. Maternal leptin concentrations, measured in early, mid, and late gestation, were positively correlated (r = 0.66; P < 0.001) and placental leptin mRNA levels were negatively correlated (r = -0.64; P < 0.01) with advancing gestational age. Maternal leptin concentrations were also correlated (r = 0.76; P < 0.01) with maternal body weight, although not with fetal birth weight (r = 0.11; P > 0.7), as measured at the time of cesarean delivery in late gestation.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 4. Expression of mRNA transcripts for leptin (A; 235 bp) and GAPDH (B; 240 bp) were demonstrated by semiquantitative RT-PCR in placental villous tissue in early (days 60–62; n = 5), mid (days 98–102; n = 5), and late (days 159–167; n = 5) gestation. The first lane in each panel contains a 1-kb DNA ladder.

 


View larger version (20K):
[in this window]
[in a new window]
 
Figure 5. Placental leptin mRNA levels determined by quantitative competitive RT-PCR (A) and maternal serum leptin concentrations (B) in early (n = 5), mid (n = 5), and late (n = 5) gestation. Values are the mean ± SEM. Different lowercase letters indicate significant differences between means (a and b, P < 0.02; c and d, P < 0.005).

 
Sections of placental villous tissue were evaluated by standard light microscopy and in situ hybridization. As depicted in Fig. 6AGo, multinucleated syncytiotrophoblasts formed a continuous surface covering of placental villi (black arrowhead) in tissue collected in early pregnancy (day 60), as determined by hematoxylin and eosin staining. Mononucleated cytotrophoblasts (white arrowhead), however, were relatively few in number. Specific in situ hybridization to leptin (Fig. 6BGo) determined transcript expression to be predominantly localized in trophoblast cells, almost exclusively to that layer of syncytiotrophoblasts encasing placental villi. The specificity of hybridization was demonstrated by use of the 5'-sense strand primer for leptin as a negative control (Fig. 6CGo). Similarly, no hybridization was determined in the absence of probe (Fig. 6DGo).



View larger version (150K):
[in this window]
[in a new window]
 
Figure 6. Representative phase contrast photomicrographs (x400) of baboon placental villous tissue. A photomicrograph depicting hematoxylin-eosin staining (A) serves as a histological reference for latter photomicrographs depicting in situ hybridization. Multinucleated syncytiotrophoblast cells (black arrowhead), mononucleated cytotrophoblast cells (white arrowhead), and intervillous space (iv) are identified. Photomicrographs depict in situ hybridization positive for leptin in early gestation (B) and negative results for leptin in situ hybridization when using the 5'-sense strand primer (C) or in the absence of probe (D).

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Leptin is an important regulator of feeding behavior, fat deposition, and energy balance in rodents (27), as receptors for the polypeptide in the hypothalamus function to mediate body weight via regulation of food intake (28). Overwhelming evidence also associates leptin with a range of processes vital to reproduction in a variety of species (4, 5, 6, 7, 8, 9, 10). During human pregnancy, maternal serum concentrations are consistently greater than those in nonpregnant women (11). Levels rise with advancing gestational age, peak during the second trimester, and remain elevated until term (12). Substantial increases in early pregnancy, before the occurrence of any notable increase in fat mass, imply that factors other than increased adiposity mediate peripheral leptin levels during gestation (29). Fetal leptin concentrations, although lower than maternal levels, are ample at term and may be at least partially due to production by fetal adipose tissue. Significantly higher concentrations in umbilical veins than in umbilical arteries, however, combined with a precipitous decline in neonatal levels immediately after birth suggest that the placenta may be an important source of leptin in the fetal circulation (30). Determination of specific leptin mRNA transcripts by RT-PCR in placental tissue at term (14, 15) and in placental tissue in both first and third trimesters by Northern analysis (13) supports this supposition. Indeed, the specific localization of leptin protein in syncytiotrophoblast by immunohistochemistry (13, 14) may indicate that at least a portion of the increase in maternal peripheral concentrations with advancing pregnancy is of placental origin. In this capacity, fetal leptin concentrations, a share of which may be produced by the syncytiotrophoblast, are highly correlated with birth weight, although no correlation exists between birth weight and maternal leptin levels (31, 32, 33). In this capacity, a putative role for the polypeptide in conceptus growth and development has been advanced. Further, mRNA transcripts for both leptin and leptin receptor have been identified in human placenta, with receptor transcripts and protein localized to the syncytiotrophoblast by both in situ hybridization (18) and immunohistochemistry (17). This suggests that the syncytiotrophoblast, a leptin-producing tissue, may also be a target for leptin action and further implies a potential for autocrine and paracrine regulatory mechanisms within this vital endocrine organ.

In the present study, we have determined that in the baboon, a nonhuman primate previously shown to be an excellent model for the study of human pregnancy (19, 20, 21, 34, 35), leptin profiles are similar to those in humans, in that maternal concentrations are enhanced during pregnancy and increase with advancing gestational age. Also, as we have previously demonstrated in human placental villous tissue (18), the expression of leptin transcripts has been localized to syncytiotrophoblast by in situ hybridization. The baboon differs from the human in one respect, however, in that the increase in leptin concentrations determined in pregnant baboons over those in nonpregnant baboons is substantially greater than the increase noted during human pregnancy. A further similarity involves the progressive decline in placental leptin mRNA transcript abundance during baboon pregnancy, which is reminiscent of our previous investigation (18) of human placental villous tissue collected both early (7–14 weeks) in gestation and at term (38 weeks). In that study, the abundance of placental leptin mRNA, quantitated by competitive RT-PCR, declined (P < 0.005) over 100-fold between early pregnancy and term. Similarly, Masuzaki et al. (13) and Yura et al. (36) had previously suggested a dramatic decline semiquantitatively via Northern analysis. In the current study, placental leptin transcript abundance declined approximately 8-fold between days 60–160 of baboon gestation, a period that is roughly equivalent to weeks 13–33 of human pregnancy. Although the potential for species differences must be acknowledged when comparing differences in leptin transcript abundance between the human and the baboon, it should also be considered that samples collected in very early human pregnancy (7–8 weeks), for which transcript abundance was exceedingly high, and those collected at human term (38 weeks), for which mRNAs were quite low, were not directly matched by samples collected in the baboon. Therefore, collection of baboon villous tissue earlier in pregnancy, after the time of the luteal-placental shift on approximately day 25 (34) and nearer term, on approximately day 184 (19, 20), may be necessary for accurate ontogenetic comparisons between species. In view of the current comparison, however, we propose that a significant increase in maternal leptin concentrations with advancing gestation combined with a general decline in leptin mRNA abundance in the syncytiotrophoblast are common features of human and baboon pregnancy.

It is evident that increases in maternal leptin levels throughout human and baboon pregnancy do not directly reflect concomitant decreases in placental leptin mRNA. Therefore, we might postulate that 1) a decline in placental leptin transcript abundance is simply not predictive of the amount of leptin protein secreted by the primate placenta; 2) the increasing mass of the syncytiotrophoblast, which increases with advancing gestation along with placental size, may be solely responsible for increases in maternal peripheral leptin concentrations; 3) the decidua and fetal membranes may function as leptin-producing tissues, contributing leptin in increasing amounts, commensurate with increasing gestational age; 4) an enhanced contribution by maternal adipose stores, stimulated by the elevated levels of estrogen or other hormones that are typical of advancing primate pregnancy, might be at least partially responsible for increased serum leptin concentrations; or 5) the increase in maternal leptin concentrations with advancing gestational age might be attributed to the action of a leptin-binding protein expressed in greater abundance, or perhaps exclusively, during pregnancy. Certainly, a variety of factors may contribute to the disparity between maternal leptin levels and placental transcript abundance with advancing gestation, although postulates 4 and 5 above deserve special consideration. Therefore, although controversial, the potential effect of estrogen may be of particular interest (37), in that estrogen has been proposed to regulate serum leptin concentrations in both humans and rats. Thus, serum leptin levels were dramatically higher in cycling women than in postmenopausal women, ostensibly in response to available estrogen (38), although recent work in our laboratory indicated no significant differences in leptin levels in cycling and postmenopausal women (23). However, in vitro, leptin secretion by adipocytes was dramatically enhanced when they were cocultured with either estradiol or hCG (39). In rats, ovariectomy acted to diminish ob gene expression in sc and retroperitoneal white adipose tissue and caused a peripheral decline in serum leptin levels, but enhanced expression in mesenteric white adipose tissue (38). Administration of exogenous estradiol reversed all of the effects of ovariectomy. Although our current work has dealt specifically with the characterization of leptin-related mechanisms within the placenta, ongoing efforts in our laboratory are addressing the potential contributions of varied maternal adipose depots to maternal leptin level throughout primate pregnancy. Finally, the potential significance of leptin-binding proteins should also be seriously considered in future investigations, as proteins with definite leptin binding capacities have been identified in nonpregnant human serum (40, 41). In this regard, a circulating form of the leptin receptor, which is a product of the placenta (42), has been shown to be enhanced in late gestation in the mouse (43). Similarly, it has been proposed that high levels of soluble leptin receptor may be of significance in the development of leptin resistance during pregnancy (44).

In summary, we have quantitated leptin in maternal serum by RIA and demonstrated the presence of leptin mRNA transcripts in the placental syncytiotrophoblast by RT-PCR and in situ hybridization in the baboon. We have further determined in this species both an increase in maternal peripheral leptin levels and a decline in placental leptin mRNA that are commensurate with advancing gestation. We have also reported that the increase in peripheral leptin concentrations, inherent in baboon pregnancy, is dramatically greater than that observed during human pregnancy and that levels decline rapidly after delivery of the conceptus. These constitute the first such observations in a nonhuman primate and, because of similarities in leptin ontogeny with that of human gestation, suggest the baboon to be a viable model for the study of leptin action in pregnancy.


    Acknowledgments
 
We express our sincere appreciation to Drs. Rudolf P. Bohm, Jr., and Marion S. Ratteree, Tulane Regional Primate Research Center, for their surgical expertise; to Mrs. Nathlynn Dellande for her assistance with the graphic design of figures; and to the Centralized Tulane Imaging Center for imaging of photomicrographs.


    Footnotes
 
1 This work was supported by NIH Research Grant R29-HD-32502 (to M.C.H.) and Grant P51-RR-00164–35 to the Tulane Regional Primate Research Center. It was presented in part at the 80th Annual Meeting of The Endocrine Society. Back

Received December 9, 1998.

Revised March 2, 1999.

Accepted March 29, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Considine RV, Caro JF. 1997 Leptin and the regulation of body weight. Int J Biochem Cell Biol. 29:1255–1272.[CrossRef][Medline]
  2. Halaas JL, Friedman JM. 1997 Obesity and the adipocyte: leptin and its receptor. J Endocrinol. 155:215–216.[CrossRef][Medline]
  3. Blum WF. 1997 Leptin: the voice of the adipose tissue. Horm Res 48(Suppl 4):2–8.
  4. Chehab FF, Lim ME, Ronghua L. 1996 Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 12:318–320.[CrossRef][Medline]
  5. Barash IA, Cheung CC, Weigle DS, Ren H, et al. 1996 Leptin is a metabolic signal to the reproductive system. Endocrinology. 137:3144–3147.[Abstract]
  6. Chehab FF, Mounzih K, Lu R, Lim ME. 1997 Early onset of reproductive function in normal female mice treated with leptin. Science. 275:88–90.[Abstract/Free Full Text]
  7. Apter D. 1997 Leptin in puberty. Clin Endocrinol (Oxf). 47:175–176.[CrossRef][Medline]
  8. Zamorano PL, Mahesh VB, DeSevilla LM, Chorich LP, Bhat GK, Brann DW. 1997 Expression and localization of the leptin receptor in endocrine and neuroendocrine tissues of the rat. Neuroendocrinology. 65:223–228.[CrossRef][Medline]
  9. Cioffi JA, Van Blerkom J, Antczak M, Shafer A, Wittmer S, Snodgrass HR. 1997 The expression of leptin and its receptor in pre-ovulatory human follicles. Mol Hum Reprod. 6:467–472.
  10. Hickey MS, Israel RG, Gardiner SN, et al. 1996 Gender differences in serum leptin levels in humans. Biochem Mol Med. 59:1–6.[CrossRef][Medline]
  11. Hardie L, Trayhurn P, Abramovich D, Fowler P. 1997 Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol (Oxf). 47:101–106.[CrossRef][Medline]
  12. Butte NF, Hopkinson JM, Nicolson MA. 1997 Leptin in human reproduction: serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab. 82:585–589.[Abstract/Free Full Text]
  13. Masuzaki H, Ogawa Y, Sagawa N, et al. 1997 Non-adipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 3:1029–1033.[CrossRef][Medline]
  14. Senaris R, Garcia-Caballaro T, Casabiell X, et al. 1997 Synthesis of leptin in human placenta. Endocrinology. 138:4501–4504.[Abstract/Free Full Text]
  15. Hassink SG, de Lancey E, Sheslow DV, et al. 1997 Placental leptin: an important new growth factor in intrauterine and neonatal development? Pediatrics. 100:1–6.[Abstract/Free Full Text]
  16. Luoh S-M, Di Marco F, Levin N, et al. 1997 Cloning and characterization of a human leptin receptor using a biologically active leptin immunoadhesin. J Mol Endocrinol. 18:77–85.[CrossRef][Medline]
  17. Amato P, Zwain IH, Yen SSC. Identification and expression of leptin receptor in human placenta: a possible role in reproduction. Proc of the 79th Annual Meet of The Endocrine Soc. 1997; 396.
  18. Henson MC, Swan KF, O’Neil JS. 1998 Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet Gynecol. 92:1020–1028.[Abstract]
  19. Henson MC. 1998 Pregnancy maintenance and the regulation of placental progesterone biosynthesis in the baboon. Hum Reprod Update. 4:389–405.[Abstract/Free Full Text]
  20. Henson MC, Pepe GJ, Albrecht ED. 1992 Developmental increase in placental low density lipoprotein uptake during baboon pregnancy. Endocrinology. 130:1698–1706.[Abstract]
  21. Henson MC, Greene SJ, Reggio BC, Shi W, Swan KF. 1997 Effects of reduced maternal lipoprotein-cholesterol availability on placental progesterone biosynthesis in the baboon. Endocrinology. 138:1385–1397.[Abstract/Free Full Text]
  22. Henson MC, Shi W, Greene SJ, Reggio BC. 1996 Effects of pregnant human, nonpregnant human, and fetal bovine sera on human chorionic gonadotopin, estradiol, and progesterone release by cultured human trophoblast cells. Endocrinology. 137:2067–2074.[Abstract]
  23. Castracane VD, Kraemer RR, Franken MA, Kraemer GR, Gimpel T. 1998 Serum leptin concentration in women: effect of age, obesity and estrogen administration. Fertil Steril. 70:472–477.[CrossRef][Medline]
  24. Chomczynski P, Sacchi N. 1997 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156–159.[CrossRef]
  25. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294–5299.[CrossRef][Medline]
  26. SAS Institutes Inc. 1989 SAS/STAT User’s guide: statistics, version 6, 4th Ed. Cary: SAS Institute; 846.
  27. Tritos NA, Mantzoros CS. 1997 Leptin: its role in obesity and beyond. Diabetologia. 40:1371–1379.[CrossRef][Medline]
  28. Friedman JM. 1998 Leptin, leptin receptors, and the control of body weight. Nutr Rev. 56:S38–S46.
  29. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. 1998 Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol. 178:1010–1015.[CrossRef][Medline]
  30. Yura S, Sagawa N, Mise H, Mori T, et al. 1998 A positive umbilical venous-arterial difference of leptin level and its rapid decline after birth. Am J Obstet Gynecol. 178:926–930.[CrossRef][Medline]
  31. Kiess W, Blum WF, Aubert ML. 1998 Leptin, puberty and reproductive function: lessons from animal studies and observations in humans. Eur J Endocrinol. 138:26–29.[CrossRef][Medline]
  32. Harigaya A, Nagashima K, Nako Y, Morikawa A,. 1997 Relationship between concentration of serum leptin and fetal growth. J Clin Endocrinol Metab. 82:3281–3284.[Abstract/Free Full Text]
  33. Tamura T, Goldenberg RL, Johnson KE, Cliver SP,. 1998 Serum leptin concentrations during pregnancy and their relationship to fetal growth. Obstet Gynecol. 91:389–395.[Abstract]
  34. Castracane VD, Goldzieher JW. 1986 Timing of the luteal-placental shift in the baboon (Papio cynocephalus). Endocrinology. 118:506–512.[Abstract]
  35. Castracane VD, Goldzieher JW. 1986 The relationship of estrogen to placental steroidogenesis in the baboon. J Clin Endocrinol Metab. 62:1163–1166.[Abstract]
  36. Yura S, Sagawa N, Ogawa Y, et al. 1998 Augmentation of leptin synthesis and secretion through activation of protein kinases A and C in cultured human trophoblastic cells. J Clin Endocrinol Metab. 83:3609–3614.[Abstract/Free Full Text]
  37. Stock SM, Bremme KA. 1998 Elevation of plasma leptin levels during pregnancy in normal and diabetic women. Metabolism. 47:840–843.[CrossRef][Medline]
  38. Shimizu H, Shimomura Y, Nakanishi Y, et al. 1997 Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol. 154:285–292.[CrossRef][Medline]
  39. Sivan E, Whittaker PG, Sinha D, et al. 1998 Leptin in human pregnancy: the relationship with gestational hormones. Am J Obstet Gynecol. 179:1128–1132.[CrossRef][Medline]
  40. Sinha MK, Opentanova I, Ohannesian JP, et al. 1996 Evidence of free and bound Leptin in human circulation, studies in lean and obese subjects and during short-term fasting. J Clin Invest. 98:1277–1282.[Medline]
  41. Diamond FB Jr, Eichler DC, Duckett G, Jorgensen EV, Shulman D, Root AW. 1997 Demonstration of a leptin binding factor in human serum. Biochem Biophys Res Commun. 233:818–822.[CrossRef][Medline]
  42. Yamaguchi M, Murakami T, Yasui Y, et al. 1998 Mouse placental cells secrete soluble leptin receptor (sOB-R): cAMP inhibits sOB-R production. Biochem Biophys Res Commun. 252:363–367.[CrossRef][Medline]
  43. Gavrilova O, Barr V, Marcus-Samuels B, Reitman M. 1997 Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor. J Biol Chem. 272:30546–30551.[Abstract/Free Full Text]
  44. Lewandowski K, Horn R, O’Callaghan CJ, et al. 1999 Free leptin, bound leptin, and soluble leptin receptor in normal and diabetic pregnancies. J Clin Endocrinol Metab. 84:300–306.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
M. C. Henson and V. D. Castracane
Leptin in Pregnancy: An Update
Biol Reprod, February 1, 2006; 74(2): 218 - 229.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
V. D. Castracane, A. G. Hendrickx, and M. C. Henson
Serum Leptin in Nonpregnant and Pregnant Women and in Old and New World Nonhuman Primates
Experimental Biology and Medicine, April 1, 2005; 230(4): 251 - 254.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. C. Schulz and E. P. Widmaier
The Effect of Leptin on Mouse Trophoblast Cell Invasion
Biol Reprod, December 1, 2004; 71(6): 1963 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. E. Edwards, R. P. Bohm Jr, J. Purcell, M. S. Ratterree, K. F. Swan, V. D. Castracane, and M. C. Henson
Two Isoforms of the Leptin Receptor Are Enhanced in Pregnancy-Specific Tissues and Soluble Leptin Receptor Is Enhanced in Maternal Serum with Advancing Gestation in the Baboon
Biol Reprod, November 1, 2004; 71(5): 1746 - 1752.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B.S.J. Yuen, P.C. Owens, M.E. Symonds, D.H. Keisler, J.R. McFarlane, K.G. Kauter, and I.C. McMillen
Effects of Leptin on Fetal Plasma Adrenocorticotropic Hormone and Cortisol Concentrations and the Timing of Parturition in the Sheep
Biol Reprod, June 1, 2004; 70(6): 1650 - 1657.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M C Henson, K F Swan, D E Edwards, G W Hoyle, J Purcell, and V D Castracane
Leptin receptor expression in fetal lung increases in late gestation in the baboon: a model for human pregnancy
Reproduction, January 1, 2004; 127(1): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Zhao, T. H. Kunz, N. Tumba, L. Clamon Schulz, C. Li, M. Reeves, and E. P. Widmaier
Comparative analysis of expression and secretion of placental leptin in mammals
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R438 - R446.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. M. Mistry and D. R. Romsos
Intracerebroventricular Leptin Administration Reduces Food Intake in Pregnant and Lactating Mice
Experimental Biology and Medicine, September 1, 2002; 227(8): 616 - 619.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. M. Seeber, J. T. Smith, and B. J. Waddell
Plasma Leptin-Binding Activity and Hypothalamic Leptin Receptor Expression During Pregnancy and Lactation in the Rat
Biol Reprod, June 1, 2002; 66(6): 1762 - 1767.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. A. Ehrhardt, A. W. Bell, and Y. R. Boisclair
Spatial and developmental regulation of leptin in fetal sheep
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1628 - R1635.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Groschl, M. Rauh, R. Wagner, W. Neuhuber, M. Metzler, G. Tamguney, J. Zenk, E. Schoof, H. G. Dorr, W. F. Blum, et al.
Identification of Leptin in Human Saliva
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5234 - 5239.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. A. Banks, J. E. Phillips-Conroy, C. J. Jolly, and J. E. Morley
Serum Leptin Levels in Wild and Captive Populations of Baboons (Papio): Implications for the Ancestral Role of Leptin
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4315 - 4320.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. S. O'Neil, A. E. Green, D. E. Edwards, K. F. Swan, T. Gimpel, V. D. Castracane, and M. C. Henson
Regulation of Leptin and Leptin Receptor in Baboon Pregnancy: Effects of Advancing Gestation and Fetectomy
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2518 - 2524.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. Henson and V. D. Castracane
Leptin in Pregnancy
Biol Reprod, November 1, 2000; 63(5): 1219 - 1228.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
N. Kronfeld-Schor, J. Zhao, B. A. Silvia, E. Bicer, P. T. Mathews, R. Urban, S. Zimmerman, T. H. Kunz, and E. P. Widmaier
Steroid-Dependent Up-Regulation of Adipose Leptin Secretion In Vitro During Pregnancy in Mice
Biol Reprod, July 1, 2000; 63(1): 274 - 280.
[Abstract] [Full Text]


Home page
Exp. Biol. Med.Home page
A. E. Green, J. S. O'neil, K. F. Swan, R. P. Bohm Jr., M. S. Ratterree, and M. C. Henson
Leptin Receptor Transcripts Are Constitutively Expressed in Placenta and Adipose Tissue with Advancing Baboon Pregnancy
Experimental Biology and Medicine, April 1, 2000; 223(4): 362 - 366.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henson, M. C.
Right arrow